CRSP

$0.00

(

0.00%

) Quote details
Add to Watchlist Run Backtest
stock

Crispr Therapeutics AG

NASDAQ | CRSP

52.74

USD

$0.00

(

0.00%

)

At Close (As of Dec 1, 2025)

$5.10B

Market Cap

-

P/E Ratio

-5.54

EPS

$78.48

52 Week High

$30.04

52 Week Low

HEALTHCARE

Sector

CRSP Chart

Recent Chart
Price Action

CRSP Technicals

Tags:

CRSP Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit -$75M
Total Revenue $35M
Cost Of Revenue $110M
Costof Goods And Services Sold $110M
Operating Income -$467M
Selling General And Administrative $73M
Research And Development $321M
Operating Expenses $391M
Investment Income Net -
Net Interest Income -
Interest Income -
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $19M
Income Before Tax -$363M
Income Tax Expense $3.6M
Interest And Debt Expense -
Net Income From Continuing Operations -$366M
Comprehensive Income Net Of Tax -
Ebit -$467M
Ebitda -$447M
Net Income -$366M

Revenue & Profitability

Earnings Performance

CRSP Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $2.2B
Total Current Assets $1.9B
Cash And Cash Equivalents At Carrying Value $298M
Cash And Short Term Investments $298M
Inventory -
Current Net Receivables $25M
Total Non Current Assets $305M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets -
Intangible Assets Excluding Goodwill -
Goodwill -
Investments -
Long Term Investments $0
Short Term Investments $1.6B
Other Current Assets $8.3M
Other Non Current Assets -
Total Liabilities $310M
Total Current Liabilities $88M
Current Accounts Payable $15M
Deferred Revenue -
Current Debt -
Short Term Debt $17M
Total Non Current Liabilities $222M
Capital Lease Obligations $224M
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $224M
Other Current Liabilities $51M
Other Non Current Liabilities $3.4M
Total Shareholder Equity $1.9B
Treasury Stock -
Retained Earnings -$1.4B
Common Stock $2.7M
Common Stock Shares Outstanding $84M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$143M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $19M
Capital Expenditures $1.9M
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment -$280M
Cashflow From Financing $332M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$366M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit -$75M
Total Revenue $35M
Cost Of Revenue $110M
Costof Goods And Services Sold $110M
Operating Income -$467M
Selling General And Administrative $73M
Research And Development $321M
Operating Expenses $391M
Investment Income Net -
Net Interest Income -
Interest Income -
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $19M
Income Before Tax -$363M
Income Tax Expense $3.6M
Interest And Debt Expense -
Net Income From Continuing Operations -$366M
Comprehensive Income Net Of Tax -
Ebit -$467M
Ebitda -$447M
Net Income -$366M

CRSP News

CRSP Profile

Crispr Therapeutics AG Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Crispr Therapeutics AG (CRSP) is a leading gene editing company at the forefront of innovation, harnessing its proprietary CRISPR/Cas9 technology to develop transformative therapies for severe genetic disorders, including sickle cell disease and beta-thalassemia. Headquartered in Zug, Switzerland, the company is not only advancing its clinical pipeline but also establishing strategic partnerships to accelerate the development and commercialization of its groundbreaking science. With a strong commitment to enhancing patient outcomes and a solid portfolio of potential therapies, Crispr Therapeutics is well-positioned to redefine the future of medicine and play a pivotal role in the biopharmaceutical landscape.

LPTX
+368.57%
$2.05
DRCT
+10.93%
$0.12
PAVS
-94.00%
$0.06
QTTB
+95.43%
$4.28
KALA
+86.31%
$1.80
HBI
-1.82%
$6.47
VINE
+21.21%
$0.48
NVDA
+1.59%
$179.83
IPG
-1.95%
$24.57
TWOH
-15.38%
$0.00
AXDX
-61.36%
$0.03
FTEL
+54.11%
$1.31
IVP
+0.08%
$0.12
ASST
-6.25%
$1.05
ADAP
-15.14%
$0.05
BITF
-6.75%
$3.24
PLUG
+1.51%
$2.01
CHR
+4.09%
$0.04
SOND
-23.45%
$0.12
BURU
-4.62%
$0.23
INTC
-1.56%
$39.92
RMBL
+60.50%
$3.21
LNW
-3.71%
$86.22
AAL
+0.12%
$14.06
ADD
-25.47%
$0.05
BIYA
+17.05%
$0.29
NFE
+18.70%
$1.44
AHMA
+140.33%
$11.56
SRM
+53.27%
$10.30
TLRY
-4.69%
$0.77
BMNR
-11.98%
$29.15
CNEY
-15.81%
$1.22
BYND
+2.87%
$1.01
RPGL
+2.39%
$0.41
BMNU
-24.74%
$6.16
IRBT
+15.18%
$1.81
NIO
-5.90%
$5.17
ONDS
-3.10%
$7.65
CLSK
-4.02%
$14.49
TSLA
-0.28%
$428.92
YGMZ
+0.17%
$0.11
WLGS
-5.57%
$0.04
MTSR
-0.35%
$70.50
SOFI
-1.05%
$29.40
F
+0.10%
$13.29
SNAP
-0.60%
$7.63
ADTX
+21.01%
$3.80
INHD
-16.59%
$0.18
MARA
-6.26%
$11.07
PFE
-1.24%
$25.41
AFMD
-34.94%
$0.18
CAN
-6.56%
$0.94
RIVN
+3.57%
$17.46
CIFR
-2.72%
$19.79
NWTN
-9.09%
$0.70
IREN
-1.32%
$47.81
MSTR
-10.92%
$157.83
GRYP
-10.38%
$1.38
PRPH
-19.10%
$0.16
HOOD
-4.68%
$122.47
MODV
-25.22%
$0.43
NCT
-29.38%
$0.54
BTBT
-7.14%
$2.20
AMZN
+0.55%
$234.51
BTG
-0.54%
$4.59
RIG
+0.80%
$4.44
AG
+2.79%
$15.65
DNN
+0.03%
$2.56
AMD
+0.47%
$218.57
T
+0.77%
$26.02
RUBI
-12.21%
$0.14
PLTR
-0.09%
$168.29
BBD
-1.35%
$3.65
VHAI
-25.00%
$0.00
GOOGL
-0.82%
$317.54
WULF
-2.40%
$15.13
ACHR
-3.72%
$7.50
EXK
-4.32%
$9.50
SAND
-6.04%
$12.12
DVLT
-4.43%
$1.94
ITUB
-1.08%
$7.71
SHOT
-74.37%
$0.39
ZAPP
-46.30%
$0.15
HBAN
+1.62%
$16.56
WBUY
+46.66%
$2.31
IBRX
-1.26%
$2.33
RGTI
-7.45%
$23.66
CRWV
+3.56%
$75.72
CPNG
-4.79%
$26.81
HL
+2.29%
$17.20
GPUS
-7.34%
$0.28
MU
+2.70%
$236.48
GRAB
-2.44%
$5.31
PLTD
+0.21%
$7.05
AAPL
+0.30%
$279.71
APLD
+3.21%
$27.97
GOOG
-0.68%
$317.92
DEFT
-12.82%
$1.32
BBWI
+9.60%
$19.08
TE
+9.58%
$4.51
LPTX
+368.57%
$2.05
DRCT
+10.93%
$0.12
PAVS
-94.00%
$0.06
QTTB
+95.43%
$4.28
KALA
+86.31%
$1.80
HBI
-1.82%
$6.47
VINE
+21.21%
$0.48
NVDA
+1.59%
$179.83
IPG
-1.95%
$24.57
TWOH
-15.38%
$0.00
AXDX
-61.36%
$0.03
FTEL
+54.11%
$1.31
IVP
+0.08%
$0.12
ASST
-6.25%
$1.05
ADAP
-15.14%
$0.05
BITF
-6.75%
$3.24
PLUG
+1.51%
$2.01
CHR
+4.09%
$0.04
SOND
-23.45%
$0.12
BURU
-4.62%
$0.23
INTC
-1.56%
$39.92
RMBL
+60.50%
$3.21
LNW
-3.71%
$86.22
AAL
+0.12%
$14.06
ADD
-25.47%
$0.05
BIYA
+17.05%
$0.29
NFE
+18.70%
$1.44
AHMA
+140.33%
$11.56
SRM
+53.27%
$10.30
TLRY
-4.69%
$0.77
BMNR
-11.98%
$29.15
CNEY
-15.81%
$1.22
BYND
+2.87%
$1.01
RPGL
+2.39%
$0.41
BMNU
-24.74%
$6.16
IRBT
+15.18%
$1.81
NIO
-5.90%
$5.17
ONDS
-3.10%
$7.65
CLSK
-4.02%
$14.49
TSLA
-0.28%
$428.92
YGMZ
+0.17%
$0.11
WLGS
-5.57%
$0.04
MTSR
-0.35%
$70.50
SOFI
-1.05%
$29.40
F
+0.10%
$13.29
SNAP
-0.60%
$7.63
ADTX
+21.01%
$3.80
INHD
-16.59%
$0.18
MARA
-6.26%
$11.07
PFE
-1.24%
$25.41
AFMD
-34.94%
$0.18
CAN
-6.56%
$0.94
RIVN
+3.57%
$17.46
CIFR
-2.72%
$19.79
NWTN
-9.09%
$0.70
IREN
-1.32%
$47.81
MSTR
-10.92%
$157.83
GRYP
-10.38%
$1.38
PRPH
-19.10%
$0.16
HOOD
-4.68%
$122.47
MODV
-25.22%
$0.43
NCT
-29.38%
$0.54
BTBT
-7.14%
$2.20
AMZN
+0.55%
$234.51
BTG
-0.54%
$4.59
RIG
+0.80%
$4.44
AG
+2.79%
$15.65
DNN
+0.03%
$2.56
AMD
+0.47%
$218.57
T
+0.77%
$26.02
RUBI
-12.21%
$0.14
PLTR
-0.09%
$168.29
BBD
-1.35%
$3.65
VHAI
-25.00%
$0.00
GOOGL
-0.82%
$317.54
WULF
-2.40%
$15.13
ACHR
-3.72%
$7.50
EXK
-4.32%
$9.50
SAND
-6.04%
$12.12
DVLT
-4.43%
$1.94
ITUB
-1.08%
$7.71
SHOT
-74.37%
$0.39
ZAPP
-46.30%
$0.15
HBAN
+1.62%
$16.56
WBUY
+46.66%
$2.31
IBRX
-1.26%
$2.33
RGTI
-7.45%
$23.66
CRWV
+3.56%
$75.72
CPNG
-4.79%
$26.81
HL
+2.29%
$17.20
GPUS
-7.34%
$0.28
MU
+2.70%
$236.48
GRAB
-2.44%
$5.31
PLTD
+0.21%
$7.05
AAPL
+0.30%
$279.71
APLD
+3.21%
$27.97
GOOG
-0.68%
$317.92
DEFT
-12.82%
$1.32
BBWI
+9.60%
$19.08
TE
+9.58%
$4.51
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.